Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| N1,N8-Diacetylspermidine hydrochloride | C11H24ClN3O2 | 178244-42-3 | Details |
| Felbamate；ADD-03055;W-554 | C11H14N2O4 | 25451-15-4 | Details |
| N1-Methylpseudouridine | C10H14N2O6 | 13860-38-3 | Details |
| N1,N8-Diacetylspermidine | C11H23N3O2 | 82414-35-5 | Details |
| N-Hydroxypipecolic acid | C6H11NO3 | 115819-92-6 | Details |
| N-Glycolylneuraminic acid | C11H19NO10 | 1113-83-3 | Details |
| H-L-Lys(Poc)-OH HCl | C10H16N2O4 | 1428330-91-9 | Details |
| N-Desmethyl imatinib-d8；Imatinib metabolite N-Desmethyl imatinib D8;N-Desmethyl imatinib D8;Norimatinib D8 | C28H29N7O | 1185103-28-9 | Details |
| N-Desmethylnefopam | C16H17NO | 46868-19-3 | Details |
| N-Hydroxypipecolic acid potassium；1-Hydroxy-2-piperidinecarboxylic acid potassium;NHP potassium | C6H12KNO3 | 2253632-01-6 | Details |
| N-Boc-O-tosyl hydroxylamine | C12H17NO5S | 105838-14-0 | Details |
| N-Desmethyl Clomipramine D3 hydrochloride；Desmethylclomipramine D3 hydrochloride | C18H22Cl2N2 | 1189971-04-7 | Details |
| N-desmethyl Enzalutamide | C20H14F4N4O2S | 1242137-16-1 | Details |
| GNE-7915 | C19H21F4N5O3 | 1351761-44-8 | Details |
| N-Biotinyl-6-aminohexanoic acid | C16H27N3O4S | 72040-64-3 | Details |
| N-Bis(2-hydroxypropyl)nitrosamine | C6H14N2O3 | 53609-64-6 | Details |
| LDN-214117 | C25H29N3O3 | 1627503-67-6 | Details |
| N-acetyl Dapsone (D4')；MADDS D4' | C14H14N2O3S | 2070015-28-8 | Details |
| N-acetyl Dapsone D4；MADDS D4 | C14H10D4N2O3S | 2070015-08-4 | Details |
| N-(3-Oxooctanoyl)-DL-homoserine lactone；(Rac)-3-oxo-C8-HSL | C12H19NO4 | 106983-27-1 | Details |
| N,N-Dimethylacetamide | C4H9NO | 127-19-5 | Details |
| N-Acetylhistamine | C7H11N3O | 673-49-4 | Details |
| M2e, human | C107H170N32O41S2 | 251359-24-7 | Details |
| Macropa-NH2 diester | C29H43N5O8 | 2146091-22-5 | Details |
| Mangafodipir trisodium | C22H25MnN4NaO14P2(-4) | 140678-14-4 | Details |
| Mebeverine alcohol D5 | C16H27NO2 | 2070015-15-3 | Details |
| Medronic acid；Methylenediphosphonic acid | CH6O6P2 | 1984-15-2 | Details |
| Urinary Incontinence-Targeting Compound 1 | C9H13FN2O3S | 137315-05-0 | Details |
| Methyl 2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetate | C12H10O5 | 15991-13-6 | Details |
| Methyl aminolevulinate | C6H12ClNO3 | 33320-16-0 | Details |
| Methyl β-D-glucopyranoside；Methyl β-D-glucoside | C7H14O6 | 709-50-2 | Details |
| Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate) | C41H43NO13S | 174264-51-8 | Details |
| Mevalonic acid | C6H12O4 | 150-97-0 | Details |
| Mito-TEMPO | 1334850-99-5 | Details |
| MK-6240 | C16H11FN4 | 1841078-87-2 | Details |
| Indacrinone；Indacrynic acid;MK-196 | C18H14Cl2O4 | 56049-88-8 | Details |
| Macrozamin | C13H24N2O11 | 6327-93-1 | Details |
| DMH-1 | C24H20N4O | 1206711-16-1 | Details |
| ML347 | C22H16N4O | 1062368-49-3 | Details |
| Methionine sulfoxide | C5H11NO3S | 62697-73-8 | Details |
| Methocarbamol D5 | C11H15NO5 | 1189699-70-4 | Details |
| Methyl cellulose | C20H38O11 | 9004-67-5 | Details |
| Methyl mycophenolate | C18H22O6 | 31858-66-9 | Details |
| LOM612 | C13H10N2O2S | 2173232-79-4 | Details |
| m-Tolylacetic acid；3-Methylbenzeneacetic acid | C9H10O2 | 621-36-3 | Details |
| m-Coumaric acid | C9H8O3 | 588-30-7 | Details |
| Leucyl-phenylalanine | C15H22N2O3 | 3063-05-6 | Details |
| GSK3787 | C15H12ClF3N2O3S | 188591-46-0 | Details |
| L-Pyrrolysine | C12H21N3O3 | 448235-52-7 | Details |
| L-Valyl-L-phenylalanine；Valylphenylalanine;H-VAL-PHE-OH | C14H20N2O3 | 3918-92-1 | Details |
| L-Praziquanamine；(+)-Praziquanamine | C12H14N2O | 99746-73-3 | Details |
| L-Octanoylcarnitine | C15H29NO4 | 25243-95-2 | Details |
| L-Ornithine L-aspartate | C5H12N2O2.C4H7NO4 | 3230-94-2 | Details |
| BTB06584 | C19H12ClNO6S | 219793-45-0 | Details |
| Iotalamic acid；Iothalamic acid | C11H9I3N2O4 | 2276-90-6 | Details |
| Ioxilan | C18H24I3N3O8 | 107793-72-6 | Details |
| Ioversol | C18H24I3N3O9 | 87771-40-2 | Details |
| INT | C19H13ClIN5O2 | 146-68-9 | Details |
| Ipfencarbazone | C18H14Cl2F2N4O2 | 212201-70-2 | Details |
| Ipsalazide | 82101-17-5 | Details |
| FLT3-IN-2 | C21H16ClF3N4 | 923562-23-6 | Details |
| Iretol | C7H8O4 | 487-71-8 | Details |
| Isobutyryl-L-carnitine | C11H21NO4 | 25518-49-4 | Details |
| Isomaltotriose | C18H32O16 | 3371-50-4 | Details |
| ITIC-4F | C94H78F4N4O2S4 | 2097998-59-7 | Details |
| ITIC | C94H82N4O2S4 | 1664293-06-4 | Details |
| Kauniolide | C15H18O2 | 81066-45-7 | Details |
| KX-01-191 | C28H39N3OSn | 2211903-84-1 | Details |
| L-Ascorbic acid 2-phosphate；2-Phospho-L-ascorbic acid | C6H9O9P | 23313-12-4 | Details |
| L-Homocysteine | C4H9NO2S | 6027-13-0 | Details |
| L-hydroxylysine dihydrochloride；(2S,5R)-5-Hydroxylysine dihydrochloride | C6H15ClN2O3 | 172213-74-0 | Details |
| L,L-Dityrosine hydrochloride | C18H20N2O6 | 221308-01-6 | Details |
| DMOG | C6H9NO5 | 89464-63-1 | Details |
| L-Homocysteine thiolactone hydrochloride | C4H8ClNOS | 31828-68-9 | Details |
| Isoguanine | C5H5N5O | 3373-53-3 | Details |
| Isovalerylcarnitine | C12H23NO4 | 31023-24-2 | Details |
| L-Ascorbic acid 2-phosphate magnesium | C6H11MgO9P | 113170-55-1 | Details |
| L-Hexanoylcarnitine | C13H25NO4 | 22671-29-0 | Details |
| L,L-Dityrosine | C18H20N2O6 | 63442-81-9 | Details |
| L-Methionine sulfoxide | C5H11NO3S | 3226-65-1 | Details |
| Myristyl nicotinate；Tetradecyl nicotinate | C20H33NO2 | 273203-62-6 | Details |
| Monooctyl succinate | C12H22O4 | 74295-86-6 | Details |
| Monomethyl fumarate-d3；Monomethyl fumarate D3 | C5H3D3O4 | 1616345-41-5 | Details |
| MTSEA hydrobromide | C3H10BrNO2S2 | 16599-33-0 | Details |
| Monocrotaline N-Oxide | C16H23NO7 | 35337-98-5 | Details |
| Moluccanin | C20H18O8 | 116521-73-4 | Details |
| Hydroxy bosentan | C27H29N5O7S | 253688-60-7 | Details |
| Hydroxycotinine | C10H12N2O2 | 34834-67-8 | Details |
| Hydroxyethyl cellulose | C29H52O21 | 9004-62-0 | Details |
| Impurity of Doxercalciferol | C28H44O2 | 127516-23-8 | Details |
| Indanazoline | C12H15N3 | 40507-78-6 | Details |
| Indium(III) isopropoxide | C3H11InO | 38218-24-5 | Details |
| Indole-3-methanamine | C9H10N2 | 22259-53-6 | Details |
| Hydroxyl-?γ-?isosanshool | C18H27NO2 | 127514-62-9 | Details |
| Hydroxypyruvic acid lithium hydrate；3-Hydroxypyruvic acid lithium hydrate;β-Hydroxypyruvic acid lithium hydrate | C3H7LiO5 | 209728-15-4 | Details |
| Hydroxypyruvic acid；3-Hydroxypyruvic acid;β-Hydroxypyruvic acid | C3H4O4 | 1113-60-6 | Details |
| Hypoglycemic agent 1 | C25H24FN5O4 | 2253733-57-0 | Details |
| Imazapic | C14H17N3O3 | 104098-48-8 | Details |
| Spautin-1 | C15H11F2N3 | 1262888-28-7 | Details |
| Hypromellose | C3H7O* | 9004-65-3 | Details |
| Product Total： Product Page： | ||||
| 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 | ||||